Variant report
Variant | nsv455907 |
---|---|
Chromosome Location | chr13:63229879-63259033 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-PCDH20-3 | chr13:63246418-63246591 | ENSG00000228669 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564441723 | chr13:63231212-63231213 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
2 | rs531751395 | chr13:63231267-63231268 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs60691111 | chr13:63231326-63231327 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs76957377 | chr13:63231349-63231350 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
5 | rs11619774 | chr13:63231354-63231355 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559723469 | chr13:63231411-63231412 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
7 | rs372524795 | chr13:63231416-63231417 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34526350 | chr13:63231421-63231422 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs547061887 | chr13:63231449-63231450 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
10 | rs565709835 | chr13:63231452-63231453 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
11 | rs192410625 | chr13:63231505-63231506 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs551606582 | chr13:63231509-63231510 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
13 | rs55930794 | chr13:63231526-63231527 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs542072841 | chr13:63231539-63231540 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs537213787 | chr13:63231572-63231573 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555628480 | chr13:63231581-63231582 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571946919 | chr13:63235473-63235474 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539375512 | chr13:63235501-63235502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs142438927 | chr13:63235560-63235561 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569518371 | chr13:63235603-63235604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs192464582 | chr13:63235648-63235649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs146302850 | chr13:63235658-63235659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147887642 | chr13:63235667-63235668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs557870806 | chr13:63235683-63235684 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs533527642 | chr13:63235694-63235695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558160606 | chr13:63235704-63235705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs74082743 | chr13:63235746-63235747 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs117275546 | chr13:63235760-63235761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs114729606 | chr13:63236093-63236094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528612727 | chr13:63236159-63236160 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs540247623 | chr13:63236161-63236162 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565320296 | chr13:63236169-63236170 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs9598479 | chr13:63236188-63236189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546211616 | chr13:63236198-63236199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs551248950 | chr13:63236276-63236277 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374493646 | chr13:63236311-63236312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs74337534 | chr13:63236386-63236387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74082744 | chr13:63236391-63236392 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs548787556 | chr13:63236393-63236394 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528815040 | chr13:63236395-63236396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs559683000 | chr13:63236405-63236406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533925686 | chr13:63236543-63236544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372417834 | chr13:63236575-63236576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558125763 | chr13:63236611-63236612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs570065181 | chr13:63236643-63236644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs537454548 | chr13:63236685-63236686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs556005630 | chr13:63236707-63236708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574698552 | chr13:63236708-63236709 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs552039015 | chr13:63236834-63236835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs553967161 | chr13:63236838-63236839 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Anaplastic thyroid cancer | 18753363 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Schizophrenia | 20967226 | CNVD |
Schizophrenia | 21346763 | CNVD |
Autism | 20531469 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:63231200-63231600 | Active TSS | Spleen | Spleen |
2 | chr13:63235400-63235800 | Enhancers | Fetal Heart | heart |
3 | chr13:63236000-63237400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
4 | chr13:63236800-63238000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr13:63237200-63238000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr13:63237400-63237600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
7 | chr13:63237600-63238600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
8 | chr13:63239000-63239200 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr13:63251800-63252600 | Active TSS | A549 | lung |
10 | chr13:63252200-63252600 | Active TSS | Osteobl | bone |
11 | chr13:63252600-63252800 | Flanking Active TSS | A549 | lung |